Silmäasema Oyj
Stock Exchange Release 
20 September 2019 at 2:30 p.m. EET

Coronaria Oy Announces Material Changes in the Number of Acceptances it Has Received Relating to the Public Tender Offer for All Shares Issued by Silmäasema Oyj – Announced Acceptances and Undertakings Together with Shares Held by Coronaria Represent Together Approximately 68.5% of the Shares in Silmäasema Oyj

Silmäasema has received the following information regarding Coronaria’s mandatory public tender offer for all shares in Silmäasema Oy:

Coronaria Oy (“Coronaria” or the “Offeror”) has on September 5, 2019 commenced a mandatory public tender offer to purchase all of the issued and outstanding shares in Silmäasema Oyj (“Silmäasema”) that are not held by the Offeror, Silmäasema or any of its subsidiaries (the “Tender Offer”). The acceptance period under the Tender Offer commenced on September 5, 2019 at 9:30 a.m. (Finnish time) and will expire on September 26, 2019 at 4:00 p.m. (Finnish time) (the “Offer Period”). The Offeror reserves the right to extend the Offer Period in accordance with the terms and conditions of the Tender Offer.

In accordance with the terms and conditions of the Tender Offer, the Offeror has committed to announce material changes in the number of valid acceptances it has received in accordance with the terms and conditions of the Tender Offer weekly. As at the date of this release, shareholders holding in the aggregate approximately 29.0% of the shares in Silmäasema have announced that they accept, or after the commencement of the Tender Offer, subject to certain customary conditions, irrevocably undertaken to accept the Tender Offer pursuant to its terms and conditions. This includes the 16.7 % of Silmäasema's shares owned by Intera Fund II Ky -fund administered by Intera Partners, concerning which shares Intera Partners has, on September 19, 2019, publicly announced that they will accept the Tender Offer. Intera Fund II Ky-fund administered by Intera Partners is, after the Offeror, the second largest shareholder of Silmäasema.

Together with shares already held by Coronaria (including approximately 6.1% shares in Silmäasema, which Coronaria has purchased through market purchases at the offer price after the publication of the tender offer document), this represents in the aggregate approximately 68.5% of all shares in Silmäasema.

Silmäasema’s operations will continue as normal and the transaction has no impact on our customers.


Jussi Salminen

For further information, please contact:

CEO Jussi Salminen, tel. +358 40 834 5818
CFO Sari Nordblad, tel. +358 50 552 7247

Mikko Merisaari, Head of Communications and Investor Relations, tel. +358 50 521 4055

Silmäasema is a Finnish company, which offers all products and services for optical retail and eye healthcare nationwide. Silmäasema is the largest private eye clinic provider offering eye surgeries and the second largest optical retail chain in Finland. The Silmäasema chain has nearly 150 stores and 13 eye clinics in Finland as well as nine stores in Estonia. The Silmäasema chain employs over 1,000 eye healthcare professionals. The Silmäasema Group’s net sales were EUR 122.9 million in 2018 and adjusted EBITDA was EUR 11.8 million.